MHE State of the Industry survey: The shift to value-based care
In this fifth part of a six-part series, data said respondents split on the effect of the pandemic on value-based care
Some see the COVID-19 pandemic as pushing American healthcare away from fee for service and into value-based care. The message from our State of the Industry survey is mixed. Almost half (46%) indicated that the pandemic had no effect on their organization’s relationship with value-based care and 9% said it had negative effect. On the other hand, 44% indicated some level of increase, including 5% who said it greatly increased value-based care.
Downside risk, which many see as essential to putting some cost-saving teeth into value-based care, still hasn’t taken hold, judging by our respondents. Two-thirds indicated that less than 25% of their value-based arrangements involved downside risk, and only 5% indicated that more than 50% of their value-based contracts involved downside risk."
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
